The global patient risk stratification market comprises predictive analytics solutions that help healthcare providers identify high-risk individuals and their risk of developing certain medical conditions. These solutions analyze patients' multiple attributes such as medical records, claims data, socio-economic factors, lifestyle parameters, family histories, and other variables to predict risks. Predictive risk stratification has enabled the shift from reactive to proactive care approach. It has become an important part of population health management as it helps providers focus interventions on patients who need it the most. The growing shift towards value-based care is also driving the adoption of risk stratification solutions to improve outcomes and reduce costs.

The Global Patient Risk Stratification Market Size Is Estimated To Be Valued At US$ 1.56 Bn In 2024 And Is Expected To Exhibit A CAGR Of 22 Over The Forecast Period 2024-2031.

Key Takeaways

Key players operating in the global patient risk stratification market are Cerner Corporation, Epic Systems Corporation, Optum, Inc., Allscripts Healthcare Solutions, Inc., Ibm Corporation, Medecision, Inc., Health Catalyst, Inc., Conifer Health Solutions, Llc, Wellcentive, Inc., Zeomega, Inc., Verscend Technologies, Inc., PreciseDx, CitiusTech Inc., Avero Diagnostics, Lightbeam Health Solutions, LexisNexis Risk Solutions, Milliman, Inc., NVision Health, RLDatix, and Verisk Analytics, Inc. These players are focusing on developing advanced AI and machine learning-enabled risk stratification solutions.

The growing burden of chronic diseases and rising healthcare costs are driving significant demand for predictive analytics solutions that can help improve outcomes and reduce costs. According to the WHO, chronic diseases account for over 70% of all deaths worldwide. Risk stratification tools help identify high-risk patients early and take preventive measures.
Technological advancements are also supporting the growth of the patient risk stratification market. Solutions increasingly leverage techniques such as artificial intelligence, machine learning, and natural language processing to generate highly accurate risk predictions. Cloud-based delivery and integration capabilities with EHR systems have also improved.

Market Trends

Increased adoption of population health management solutions - Population health management involves coordinating care across the healthcare ecosystem and keeping communities healthy. Risk stratification tools are critical elements of PHM programs to identify at-risk individuals. Their adoption is rising globally.
Growing focus on value-based care - The shift from fee-for-service to value-based reimbursement models is driving increased focus on improving outcomes and reducing costs. Risk stratification solutions help achieve these goals by guiding resources and interventions to high-risk patients.

Market Opportunities

Integration of social determinants of health data - Social and economic factors greatly influence populations' health. Incorporating social determinants data can significantly boost risk prediction accuracy.
Real-world evidence generation - Utilizing real-world data from EHRs, claims, and clinical outcomes can help risk tools learn from real patient journeys and populations. This continual learning improves models over time.

Impact Of COVID-19 On Global Patient Risk Stratification Market Growth

The COVID-19 pandemic has significantly impacted the growth of the global patient risk stratification market. During the initial phases of the pandemic, most elective medical procedures and non-emergency healthcare services were postponed to prioritize the treatment of COVID-19 patients. This led to a decline in the adoption of patient risk stratification solutions as healthcare resources were diverted towards handling the pandemic. However, as the pandemic progressed, the demand for remote patient monitoring and virtual care delivery using digital platforms increased tremendously. Patient risk stratification solutions enable providers to identify at-risk individuals and prioritize their care needs remotely. This allows providers to better manage their resources and ensures continuity of care for chronic patients during crises. The pandemic has also highlighted the importance of population health management and value-based care models which rely on data-driven risk stratification of patient cohorts. Several healthcare organizations have accelerated their digital transformation initiatives and are increasingly adopting patient risk stratification solutions to enhance clinical outcomes. With growing focus on value-based reimbursements, the long-term impact of the pandemic on the market is expected to be positive as risk adjustment and stratification becomes more critical for healthcare ecosystem sustainability.

Geographical Regions With Highest Value Concentration In Global Patient Risk Stratification Market

In terms of value, North America dominates the global patient risk stratification market currently with the United States accounting for the highest revenue share. This can be attributed to rising healthcare costs in the country, growing prevalence of chronic diseases, superior infrastructure for data analytics capabilities, and gradual shift towards quality-based reimbursement models. Europe holds the second largest market share owing to initiatives like National Health Service (NHS) Long Term Plan focusing on integrated care delivery through population risk management. The Asia Pacific region is expected to grow at the fastest rate during the forecast period due to increasing healthcare expenditure, high unmet clinical needs, and growing adoption of advanced data-driven technologies in countries like China and India. Initiatives to promote digital health are further expected to support market growth across emerging markets.

Geographical Region with Fastest Growth in Global Patient Risk Stratification Market
Asia Pacific region is poised to exhibit the highest growth rate in the global patient risk stratification market during the forecast period from 2024 to 2031. Rapid economic development, rising burden of chronic diseases, growing focus on preventive healthcare to control costs, and initiatives to modernize healthcare infrastructure positively impact the adoption of digital and data-driven solutions like patient risk stratification in the region. Countries like China and India represent huge market opportunities due to their massive population base and increasing spending on healthcare IT. Growing investments by global market players also accelerate the technology diffusion. Favorable regulations, improving IT capabilities, and increasing focus on value-based care models help sustain the momentum. Asia Pacific has shown early signs of recovery from the pandemic's impact as well. All these factors contribute to Asia Pacific emerging as the fastest growing regional market for patient risk stratification globally.

What are the key data covered in this Global Patient Risk Stratification Market report?

:- Market CAGR throughout the predicted period

:- Comprehensive information on the aspects that will drive the Global Patient Risk Stratification Market's growth between 2024 and 2031.

:- Accurate calculation of the size of the Global Patient Risk Stratification  Market and its contribution to the market, with emphasis on the parent market

:- Realistic forecasts of future trends and changes in consumer behavior

:- Global Patient Risk Stratification  Market Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa

:- A complete examination of the market's competitive landscape, as well as extensive information on vendors

:- Detailed examination of the factors that will impede the expansion of Global Patient Risk Stratification  Market vendors

FAQ’s

Q.1 What are the main factors influencing the Global Patient Risk Stratification market?
Q.2 Which companies are the major sources in this industry?
Q.3 What are the market’s opportunities, risks, and general structure?
Q.4 Which of the top Global Patient Risk Stratification Market companies compare in terms of sales, revenue, and prices?
Q.5 Which businesses serve as the Global Patient Risk Stratification market’s distributors, traders, and dealers?
Q.6 How are market types and applications and deals, revenue, and value explored?
Q.7 What does a business area’s assessment of agreements, income, and value implicate?

Get more insights on this topic: https://www.pressreleasebulletin.com/global-patient-risk-stratification-market-trend-size-and-demand/